Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

1.

The BeSt way of withdrawing biologic agents.

Allaart CF, Lems WF, Huizinga TW.

Clin Exp Rheumatol. 2013 Jul-Aug;31(4 Suppl 78):S14-8. Epub 2013 Oct 3.

PMID:
24129130
[PubMed - indexed for MEDLINE]
2.

Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study.

Allaart CF, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Breedveld FC, Dijkmans BA; FARR study group.

Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S-77-82.

PMID:
17083767
[PubMed - indexed for MEDLINE]
3.

Treatment of recent-onset rheumatoid arthritis: lessons from the BeSt study.

Allaart CF, Breedveld FC, Dijkmans BA.

J Rheumatol Suppl. 2007 Nov;80:25-33.

PMID:
17985420
[PubMed - indexed for MEDLINE]
4.

Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis.

van der Kooij SM, le Cessie S, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, van Zeben D, Kerstens PJ, Hazes JM, van Schaardenburg D, Breedveld FC, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2009 Jul;68(7):1153-8. doi: 10.1136/ard.2008.093294. Epub 2008 Oct 17.

PMID:
18930988
[PubMed - indexed for MEDLINE]
5.

Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study.

van den Broek M, Klarenbeek NB, Dirven L, van Schaardenburg D, Hulsmans HM, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2011 Aug;70(8):1389-94. doi: 10.1136/ard.2010.147751. Epub 2011 Apr 24.

PMID:
21515916
[PubMed - indexed for MEDLINE]
6.

Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis.

van der Kooij SM, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Güler-Yüksel M, Zwinderman AH, Kerstens PJ, van der Lubbe PA, de Beus WM, Grillet BA, Ronday HK, Huizinga TW, Breedveld FC, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2009 Jun;68(6):914-21. doi: 10.1136/ard.2008.092254. Epub 2008 Jul 28.

PMID:
18662933
[PubMed - indexed for MEDLINE]
7.

Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis.

van der Bijl AE, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Ten Wolde S, Han KH, van Krugten MV, Allaart CF, Breedveld FC, Dijkmans BA.

Arthritis Rheum. 2007 Jul;56(7):2129-34.

PMID:
17599726
[PubMed - indexed for MEDLINE]
Free Article
8.

Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score.

van der Kooij SM, de Vries-Bouwstra JK, Goekoop-Ruiterman YP, van Zeben D, Kerstens PJ, Gerards AH, van Groenendael JH, Hazes JM, Breedveld FC, Allaart CF, Dijkmans BA.

Ann Rheum Dis. 2007 Oct;66(10):1356-62. Epub 2007 Feb 9.

PMID:
17293364
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Discontinuation of biologics in patients with rheumatoid arthritis.

Tanaka Y, Hirata S, Saleem B, Emery P.

Clin Exp Rheumatol. 2013 Jul-Aug;31(4 Suppl 78):S22-7. Epub 2013 Oct 3. Review.

PMID:
24129132
[PubMed - indexed for MEDLINE]
10.

Rescue of combination therapy failures using infliximab, while maintaining the combination or monotherapy with methotrexate: results of an open trial.

Ferraccioli GF, Assaloni R, Di Poi E, Gremese E, De Marchi G, Fabris M.

Rheumatology (Oxford). 2002 Oct;41(10):1109-12.

PMID:
12364628
[PubMed - indexed for MEDLINE]
Free Article
11.

Discontinuation of infliximab in rheumatoid arthritis patients in clinical remission.

Nawata M, Saito K, Nakayamada S, Tanaka Y.

Mod Rheumatol. 2008;18(5):460-4. doi: 10.1007/s10165-008-0089-1. Epub 2008 Jun 6.

PMID:
18535759
[PubMed - indexed for MEDLINE]
12.

Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study).

Nam JL, Villeneuve E, Hensor EM, Conaghan PG, Keen HI, Buch MH, Gough AK, Green MJ, Helliwell PS, Keenan AM, Morgan AW, Quinn M, Reece R, van der Heijde DM, Wakefield RJ, Emery P.

Ann Rheum Dis. 2014 Jan;73(1):75-85. doi: 10.1136/annrheumdis-2013-203440. Epub 2013 Aug 2.

PMID:
23912798
[PubMed - indexed for MEDLINE]
13.

Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.

Zintzaras E, Dahabreh IJ, Giannouli S, Voulgarelis M, Moutsopoulos HM.

Clin Ther. 2008 Nov;30(11):1939-55. doi: 10.1016/j.clinthera.2008.11.007. Review.

PMID:
19108784
[PubMed - indexed for MEDLINE]
14.

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.

Chen YF, Jobanputra P, Barton P, Jowett S, Bryan S, Clark W, Fry-Smith A, Burls A.

Health Technol Assess. 2006 Nov;10(42):iii-iv, xi-xiii, 1-229. Review.

PMID:
17049139
[PubMed - indexed for MEDLINE]
Free Article
15.

Can we discontinue synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis?

Scott IC, Kingsley GH, Scott DL.

Clin Exp Rheumatol. 2013 Jul-Aug;31(4 Suppl 78):S4-8. Epub 2013 Oct 3. Review.

PMID:
24129128
[PubMed - indexed for MEDLINE]
16.

Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial.

Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, Zwinderman AH, Peeters AJ, de Jonge-Bok JM, Mallée C, de Beus WM, de Sonnaville PB, Ewals JA, Breedveld FC, Dijkmans BA.

Ann Intern Med. 2007 Mar 20;146(6):406-15.

PMID:
17371885
[PubMed - indexed for MEDLINE]
17.

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.

Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, Zwinderman AH, Ronday HK, Han KH, Westedt ML, Gerards AH, van Groenendael JH, Lems WF, van Krugten MV, Breedveld FC, Dijkmans BA.

Arthritis Rheum. 2005 Nov;52(11):3381-90.

PMID:
16258899
[PubMed - indexed for MEDLINE]
Free Article
18.

Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade.

Smolen JS, Han C, van der Heijde DM, Emery P, Bathon JM, Keystone E, Maini RN, Kalden JR, Aletaha D, Baker D, Han J, Bala M, St Clair EW; Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset (ASPIRE) Study Group.

Ann Rheum Dis. 2009 Jun;68(6):823-7. doi: 10.1136/ard.2008.090019. Epub 2008 Jul 1. Erratum in: Ann Rheum Dis. 2011 Aug;70(8):1519.

PMID:
18593759
[PubMed - indexed for MEDLINE]
19.

Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial.

Soubrier M, Puéchal X, Sibilia J, Mariette X, Meyer O, Combe B, Flipo RM, Mulleman D, Berenbaum F, Zarnitsky C, Schaeverbeke T, Fardellone P, Dougados M.

Rheumatology (Oxford). 2009 Nov;48(11):1429-34. doi: 10.1093/rheumatology/kep261. Epub 2009 Sep 9.

PMID:
19741011
[PubMed - indexed for MEDLINE]
Free Article
20.

BeSt practice: the success of early-targeted treatment in rheumatoid arthritis.

van den Broek M, Lems WF, Allaart CF.

Clin Exp Rheumatol. 2012 Jul-Aug;30(4 Suppl 73):S35-8. Epub 2012 Oct 18.

PMID:
23078756
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk